Bumetanide to treat autism spectrum disorders: Clinical observations
Éric Lemonnier(Laboratoire Pluridisciplinaire de Recherche en Ingénierie des Systèmes, Mécanique et Energétique), Yehezkel Ben‐Ari(Neurochlore (France)), Denis Ravel(Neurochlore (France)), Nouchine Hadjikhani(Harvard University Press)
Cited by 0
Related Papers
X-Linked Mental Retardation and Autism Are Associated with a Mutation in the NLGN4 Gene, a Member of the Neuroligin Family
|The American Journal of Human Genetics|2004|762
Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring
|Science|2014|587
A randomised controlled trial of bumetanide in the treatment of autism in children
|Translational Psychiatry|2012|310
Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
|Translational Psychiatry|2017|210